Iria Pharma, LLC

Company Information
Address 60 Hazelwood Dr Ste 230
Champaign, IL, 61820-7460


DUNS: 080457622

# of Employees: 2

Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N

Award Charts

Award Listing

  1. Targeted Small Molecular Mertansine Delivery for Triple Negative Breast Cancer Treatment

    Amount: $300,000.00

    Project Summary Triple negative breast cancerTNBCis a subtype of breast cancerthat occurs in aboutof diagnosed breast cancerswhich is more likely to affect younger peopleAfrican AmericansHispanicsand ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  2. SBIR Phase I: Targeted Small Molecular Taxane Delivery for Triple Negative Breast Cancer Treatment

    Amount: $225,000.00

    This SBIR Phase I project proposes to develop a novel cancer targeting technology, Active Tissue Targeting via Anchored ClicK Chemistry (ATTACK), for targeted treatment of triple negative breast cance ...

    SBIRPhase I2018National Science Foundation
US Flag An Official Website of the United States Government